Home/Filings/4/0001193125-25-286226
4//SEC Filing

Henn Matthew R 4

Accession 0001193125-25-286226

CIK 0001609809other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:30 PM ET

Size

16.1 KB

Accession

0001193125-25-286226

Insider Transaction Report

Form 4
Period: 2025-11-15
Henn Matthew R.
See Remarks
Transactions
  • Sale

    Common Stock

    2025-11-15$17.30/sh1,257$21,7467,527 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-11-15140704 total
    Common Stock (140 underlying)
  • Exercise/Conversion

    Common Stock

    2025-11-15+3,9988,546 total
  • Exercise/Conversion

    Common Stock

    2025-11-15+988,784 total
  • Exercise/Conversion

    Common Stock

    2025-11-15+1408,686 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-11-1598878 total
    Common Stock (98 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-11-153,9980 total
    Common Stock (3,998 underlying)
Footnotes (5)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on April 13, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units.
  • [F3]The RSUs vested in a single installment on November 15, 2025. The RSUs have no expiration date.
  • [F4]The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.
  • [F5]The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.

Documents

1 file

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeother

Related Parties

1
  • filerCIK 0001767321

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:30 PM ET
Size
16.1 KB